» Articles » PMID: 29316637

Bacterial Production, Characterization and Protein Modeling of a Novel Monofuctional Isoform of FAD Synthase in Humans: An Emergency Protein?

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2018 Jan 11
PMID 29316637
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

FAD synthase (FADS, EC 2.7.7.2) is the last essential enzyme involved in the pathway of biosynthesis of Flavin cofactors starting from Riboflavin (Rf). Alternative splicing of the human FLAD1 gene generates different isoforms of the enzyme FAD synthase. Besides the well characterized isoform 1 and 2, other FADS isoforms with different catalytic domains have been detected, which are splice variants. We report the characterization of one of these novel isoforms, a 320 amino acid protein, consisting of the sole C-terminal 3'-phosphoadenosine 5'-phosphosulfate (PAPS) reductase domain (named FADS6). This isoform has been previously detected in Riboflavin-Responsive (RR-MADD) and Non-responsive Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) patients with frameshift mutations of FLAD1 gene. To functionally characterize the hFADS6, it has been over-expressed in and purified with a yield of 25 mg·L of cell culture. The protein has a monomeric form, it binds FAD and is able to catalyze FAD synthesis (k about 2.8 min), as well as FAD pyrophosphorolysis in a strictly Mg-dependent manner. The synthesis of FAD is inhibited by HgCl₂. The enzyme lacks the ability to hydrolyze FAD. It behaves similarly to PAPS. Combining threading and ab-initio strategy a 3D structural model for such isoform has been built. The relevance to human physio-pathology of this FADS isoform is discussed.

Citing Articles

Revitalising Riboflavin: Unveiling Its Timeless Significance in Human Physiology and Health.

Aragao M, Pires L, Santos-Buelga C, Barros L, Calhelha R Foods. 2024; 13(14).

PMID: 39063339 PMC: 11276209. DOI: 10.3390/foods13142255.


New insights into the nutritional genomics of adult-onset riboflavin-responsive diseases.

Murgia C, Dehlia A, Guthridge M Nutr Metab (Lond). 2023; 20(1):42.

PMID: 37845732 PMC: 10580530. DOI: 10.1186/s12986-023-00764-x.


Riboflavin kinase and pyridoxine 5'-phosphate oxidase complex formation envisages transient interactions for FMN cofactor delivery.

Rivero M, Boneta S, Novo N, Velazquez-Campoy A, Polo V, Medina M Front Mol Biosci. 2023; 10:1167348.

PMID: 37056721 PMC: 10086132. DOI: 10.3389/fmolb.2023.1167348.


Mining the Flavoproteome of Brucella ovis, the Brucellosis Causing Agent in Ovis aries.

Minjarez-Saenz M, Martinez-Julvez M, Yruela I, Medina M Microbiol Spectr. 2022; 10(2):e0229421.

PMID: 35315701 PMC: 9045290. DOI: 10.1128/spectrum.02294-21.


Purification and characterization of recombinant FAD synthetase from .

Puvvada N, Gunde S, Ramana Devi C, Gogada R Biochem Biophys Rep. 2021; 28:101161.

PMID: 34765745 PMC: 8571487. DOI: 10.1016/j.bbrep.2021.101161.


References
1.
Finnegan S, Yuan H, Wang Y, Orville A, Weber I, Gadda G . Structural and kinetic studies on the Ser101Ala variant of choline oxidase: catalysis by compromise. Arch Biochem Biophys. 2010; 501(2):207-13. DOI: 10.1016/j.abb.2010.06.014. View

2.
Miccolis A, Galluccio M, Giancaspero T, Indiveri C, Barile M . Bacterial over-expression and purification of the 3'phosphoadenosine 5'phosphosulfate (PAPS) reductase domain of human FAD synthase: functional characterization and homology modeling. Int J Mol Sci. 2013; 13(12):16880-98. PMC: 3546728. DOI: 10.3390/ijms131216880. View

3.
McCormick D . A trail of research on cofactors: an odyssey with friends. J Nutr. 2000; 130(2S Suppl):323S-330S. DOI: 10.1093/jn/130.2.323S. View

4.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

5.
Torchetti E, Brizio C, Colella M, Galluccio M, Giancaspero T, Indiveri C . Mitochondrial localization of human FAD synthetase isoform 1. Mitochondrion. 2010; 10(3):263-73. DOI: 10.1016/j.mito.2009.12.149. View